These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31520455)

  • 1. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction.
    Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
    Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA
    Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
    Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
    Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
    Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
    J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
    PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.
    Schauer A; Adams V; Kämmerer S; Langner E; Augstein A; Barthel P; Männel A; Fabig G; Alves PKN; Günscht M; El-Armouche A; Müller-Reichert T; Linke A; Winzer EB
    Circ Heart Fail; 2024 Jun; 17(6):e011107. PubMed ID: 38847102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
    Neves JS; Leite AR; Conceição G; Gonçalves A; Borges-Canha M; Vale C; Von-Hafe M; Martins D; Miranda-Silva D; Leite S; Rocha-Oliveira E; Sousa-Mendes C; Chaves J; Lourenço IM; Grijota-Martínez C; Bárez-López S; Miranda IM; Almeida-Coelho J; Vasques-Nóvoa F; Carvalho D; Lourenço A; Falcão-Pires I; Leite-Moreira A
    Thyroid; 2023 Aug; 33(8):983-996. PubMed ID: 37140469
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.
    Bode D; Semmler L; Wakula P; Hegemann N; Primessnig U; Beindorff N; Powell D; Dahmen R; Ruetten H; Oeing C; Alogna A; Messroghli D; Pieske BM; Heinzel FR; Hohendanner F
    Cardiovasc Diabetol; 2021 Jan; 20(1):7. PubMed ID: 33413413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid frequency-dependent changes in free mitochondrial calcium concentration in rat cardiac myocytes.
    Wüst RC; Helmes M; Martin JL; van der Wardt TJ; Musters RJ; van der Velden J; Stienen GJ
    J Physiol; 2017 Mar; 595(6):2001-2019. PubMed ID: 28028811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
    van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
    Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
    Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
    Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct features of calcium handling and β-adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction.
    Kilfoil PJ; Lotteau S; Zhang R; Yue X; Aynaszyan S; Solymani RE; Cingolani E; Marbán E; Goldhaber JI
    J Physiol; 2020 Nov; 598(22):5091-5108. PubMed ID: 32829489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
    Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the gut microbiome, associated metabolites and the manifestation and progression of heart failure with preserved ejection fraction in ZSF1 rats.
    Guivala SJ; Bode KA; Okun JG; Kartal E; Schwedhelm E; Pohl LV; Werner S; Erbs S; Thiele H; Büttner P
    Cardiovasc Diabetol; 2024 Aug; 23(1):299. PubMed ID: 39143579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure.
    Abdellatif M; Leite S; Alaa M; Oliveira-Pinto J; Tavares-Silva M; Fontoura D; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H4-13. PubMed ID: 26475584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF.
    Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M
    J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.
    Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.
    Bowen TS; Brauer D; Rolim NPL; Bækkerud FH; Kricke A; Ormbostad Berre AM; Fischer T; Linke A; da Silva GJ; Wisloff U; Adams V
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
    PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.